Related Articles
Phase II trial of concurrent chemoradiotherapy with S‑1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma
Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients
Concurrent chemoradiotherapy with nedaplatin in patients with stage IIA to IVA cervical carcinoma
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial
Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients